Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 gene

J Gen Virol. 2009 Sep;90(Pt 9):2107-13. doi: 10.1099/vir.0.009209-0. Epub 2009 May 7.

Abstract

Among the structural and nonstructural proteins of severe acute respiratory syndrome coronavirus (SARS-CoV), the nucleocapsid (N) protein plays pivotal roles in the biology and pathogenesis of viral infection. N protein is thought to dysregulate cell signalling and the transcription of cellular genes, including FGL2, which encodes a prothrombinase implicated in vascular thrombosis, fibrin deposition and pneumocyte necrosis. Here, we showed that N protein expressed in cultured human cells was predominantly found in the cytoplasm and was competent in repressing the transcriptional activity driven by interferon-stimulated response elements. However, the expression of N protein did not influence the transcription from the FGL2 promoter. More importantly, N protein did not modulate the expression of FGL2 mRNA or protein in transfected or SARS-CoV-infected cells. Taken together, our findings did not support the model in which SARS-CoV N protein specifically modulates transcription of the FGL2 gene to cause fibrosis and vascular thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Coronavirus Nucleocapsid Proteins
  • Fibrinogen / genetics*
  • Fibrinogen / metabolism
  • Humans
  • Nucleocapsid Proteins / genetics
  • Nucleocapsid Proteins / metabolism*
  • Severe Acute Respiratory Syndrome / genetics*
  • Severe Acute Respiratory Syndrome / metabolism
  • Severe Acute Respiratory Syndrome / virology
  • Severe acute respiratory syndrome-related coronavirus / genetics
  • Severe acute respiratory syndrome-related coronavirus / metabolism*
  • Transcription, Genetic*

Substances

  • Coronavirus Nucleocapsid Proteins
  • FGL2 protein, human
  • Nucleocapsid Proteins
  • Fibrinogen